BHC
What one share of Bausch Health Companies holds
Pharmaceutical Preparations
Bausch Health Companies Inc.
Bausch Health Companies’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $28.93 |
|---|---|
| Profit | −$2.93 |
| Capex (buildings and equipment) | $0.98 |
| Free cash flow | $3.81 |
| Cash and investments | $4.88 |
| Debt | $55.47 |
| Book value | −$4.74 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $27.85 | −$6.94 | $0.68 | $5.33 | — | $9.06 |
| 2017 | $24.80 | $6.83 | $0.49 | $6.02 | — | $16.77 |
| 2018 | $23.85 | −$11.81 | $0.45 | $3.83 | — | $7.81 |
| 2019 | $24.43 | −$5.08 | $0.77 | $3.50 | — | $3.02 |
| 2020 | $22.61 | −$1.58 | $0.85 | $2.28 | — | $1.51 |
| 2021 | $23.50 | −$2.64 | $0.75 | $3.22 | — | −$0.29 |
| 2022 | $22.44 | −$0.62 | $0.60 | −$2.61 | — | −$1.91 |
| 2023 | $24.00 | −$1.62 | $0.59 | $2.24 | — | −$2.80 |
| 2024 | $26.15 | −$0.12 | $0.92 | $3.42 | — | −$3.48 |
| 2025 | $27.38 | $0.42 | $1.06 | $2.67 | — | −$1.50 |